Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 2
2009 2
2011 2
2012 5
2013 4
2014 6
2015 7
2016 21
2017 9
2018 10
2019 17
2020 31
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32680878

104 results
Results by year
Filters applied: . Clear all
Page 1
Ruxolitinib in Alleviating the Cytokine Storm of Hemophagocytic Lymphohistiocytosis.
Jianguo L, Zhixuan Z, Rong L, Xiaodong S. Jianguo L, et al. Pediatrics. 2020 Aug;146(2):e20191301. doi: 10.1542/peds.2019-1301. Epub 2020 Jul 17. Pediatrics. 2020. PMID: 32680878
A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis.
Zhang Q, Wei A, Ma HH, Zhang L, Lian HY, Wang D, Zhao YZ, Cui L, Li WJ, Yang Y, Wang TY, Li ZG, Zhang R. Zhang Q, et al. Haematologica. 2020 Jul 30:haematol.2020.253781. doi: 10.3324/haematol.2020.253781. Online ahead of print. Haematologica. 2020. PMID: 32732367
Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report.
Sin JH, Zangardi ML. Sin JH, et al. Hematol Oncol Stem Cell Ther. 2019 Sep;12(3):166-170. doi: 10.1016/j.hemonc.2017.07.002. Epub 2017 Aug 16. Hematol Oncol Stem Cell Ther. 2019. PMID: 28834694 Free article.
Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children.
Wei A, Ma H, Li Z, Zhang L, Zhang Q, Wang D, Lian H, Zhang R, Wang T. Wei A, et al. Int J Hematol. 2020 Jul 14. doi: 10.1007/s12185-020-02936-4. Online ahead of print. Int J Hematol. 2020. PMID: 32666469
Low dose ruxolitinib plus HLH-94 protocol: A potential choice for secondary HLH.
Wang H, Gu J, Liang X, Mao X, Wang Z, Huang W. Wang H, et al. Semin Hematol. 2020 Jan;57(1):26-30. doi: 10.1053/j.seminhematol.2018.07.006. Epub 2019 Feb 27. Semin Hematol. 2020. PMID: 32690141
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M, Atagündüz P, Atagündüz I, Sucak GT. Soy M, et al. Rheumatol Int. 2020 Jun 25:1-12. doi: 10.1007/s00296-020-04636-y. Online ahead of print. Rheumatol Int. 2020. PMID: 32588191 Free PMC article. Review.
Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
Das R, Guan P, Sprague L, Verbist K, Tedrick P, An QA, Cheng C, Kurachi M, Levine R, Wherry EJ, Canna SW, Behrens EM, Nichols KE. Das R, et al. Blood. 2016 Mar 31;127(13):1666-75. doi: 10.1182/blood-2015-12-684399. Epub 2016 Jan 29. Blood. 2016. PMID: 26825707 Free PMC article.
Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
Brisse E, Imbrechts M, Put K, Avau A, Mitera T, Berghmans N, Rutgeerts O, Waer M, Ninivaggi M, Kelchtermans H, Boon L, Snoeck R, Wouters CH, Andrei G, Matthys P. Brisse E, et al. J Immunol. 2016 Apr 1;196(7):3124-34. doi: 10.4049/jimmunol.1501035. Epub 2016 Feb 22. J Immunol. 2016. PMID: 26903481 Free article.
104 results
Jump to page
Feedback